AAAAAA

   
Results: 1-7 |
Results: 7
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality
Authors: Dash, R Kadambi, VJ Schmidt, AG Tepe, NM Biniakiewicz, D Gerst, MJ Canning, AM Abraham, WT Hoit, BD Liggett, SB Lorenz, JN Dorn, GW Kranias, EG
Citation: R. Dash et al., Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, CIRCULATION, 103(6), 2001, pp. 889-896
Functional receptor coupling to G(i) is mechanism of agonist-promoted desensitization of the beta(2)-adrenergic receptor
Authors: Tepe, NM Liggett, SB
Citation: Nm. Tepe et Sb. Liggett, Functional receptor coupling to G(i) is mechanism of agonist-promoted desensitization of the beta(2)-adrenergic receptor, J RECEPT SI, 20(1), 2000, pp. 75-85
Mechanisms of impaired beta-adrenergic receptor signaling in G(alpha q)-mediated cardiac hypertrophy and ventricular dysfunction
Authors: Dorn, GW Tepe, NM Wu, GY Yatani, A Liggett, SB
Citation: Gw. Dorn et al., Mechanisms of impaired beta-adrenergic receptor signaling in G(alpha q)-mediated cardiac hypertrophy and ventricular dysfunction, MOLEC PHARM, 57(2), 2000, pp. 278-287
Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts - Critical role for expression level
Authors: Liggett, SB Tepe, NM Lorenz, JN Canning, AM Jantz, TD Mitarai, S Yatani, A Dorn, GW
Citation: Sb. Liggett et al., Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts - Critical role for expression level, CIRCULATION, 101(14), 2000, pp. 1707-1714
Low- and high-level transgenic expression of beta(2)-adrenergic receptors differentially affect cardiac hypertrophy and function in G alpha q-overexpressing mice
Authors: Dorn, GW Tepe, NM Lorenz, JN Koch, WJ Liggett, SB
Citation: Gw. Dorn et al., Low- and high-level transgenic expression of beta(2)-adrenergic receptors differentially affect cardiac hypertrophy and function in G alpha q-overexpressing mice, P NAS US, 96(11), 1999, pp. 6400-6405
Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G(alpha q) overexpressing mouse
Authors: Tepe, NM Liggett, SB
Citation: Nm. Tepe et Sb. Liggett, Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G(alpha q) overexpressing mouse, FEBS LETTER, 458(2), 1999, pp. 236-240
Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling
Authors: Tepe, NM Lorenz, JN Yatani, A Dash, R Kranias, EG Dorn, GW Liggett, SB
Citation: Nm. Tepe et al., Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling, BIOCHEM, 38(50), 1999, pp. 16706-16713
Risultati: 1-7 |